Immix Biopharma Inc (IMMX)

NASDAQ
2.60
0.00(0.00%)
After Hours
2.55
-0.05(-1.92%)
- Real-time Data
  • Volume:
    277,896
  • Day's Range:
    2.42 - 2.65
  • 52 wk Range:
    1.25 - 8.68

IMMX Overview

Prev. Close
2.6
Day's Range
2.42-2.65
Revenue
-
Open
2.42
52 wk Range
1.25-8.68
EPS
-
Volume
277,896
Market Cap
36.1M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,971,901
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
13,885,004
Next Earnings Date
-
What is your sentiment on Immix Biopharma?
or
Market is currently closed. Voting is open during market hours.

Immix Biopharma Inc News

Immix Biopharma Inc Company Profile

Immix Biopharma Inc Company Profile

Employees
2

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn’s disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyStrong BuyBuy
Technical IndicatorsSellBuyStrong BuyStrong BuyBuy
SummarySellBuyStrong BuyStrong BuyBuy
  • I need to teach me a bout this market
    1